Another big one.
From The Standard (U.K.), July 22:
Donald Trump is expected to announce tariffs of up to 200% on drugs makers in August
British pharmaceuticals giant AstraZeneca has revealed it plans to invest $50 billion (£37 billion) in America over the next five years.
The investment will be made in medicines manufacturing and R&D, and create tens of thousands of high skilled jobs, the Cambridge based company said.
By 2030 half the company’s expected $80 billion of revenues will be generated in the USA.
The investments will include a new multi-billion dollar drug substance manufacturing centre focused on chronic diseases in Virginia. It will be the company’s biggest commitment to a single facility anywhere in the world.
It will produce drug substances for the company's weight management and metabolic portfolio, including oral GLP-1, baxdrostat, oral PCSK9 and combination small molecule products.
The $50 billion investment also includes: Expansion of an R&D facility in Gaithersburg, Maryland; an R&D centre in Kendall Square, Cambridge, Massachusetts; manufacturing facilities for cell therapy in Rockville, Maryland and Tarzana, California; continuous manufacturing expansion in Mount Vernon, Indiana; and specialty manufacturing expansion in Coppell, Texas....
....MUCH MORE
So far in this series:
Another One: "Amgen to expand Ohio biotech manufacturing plant"
The one that really stood out for us was "Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years" because it followed so closely on the warning from the EFPIA (also because of the 50 large, that's a lot of money, no matter who you are):
Another One: "Bristol Myers to invest $40 billion in the US over 5 years, CEO says"...April 13's "Pharma CEOs alert President von der Leyen to risk of exodus to the US" on The European Federation of Pharmaceutical Industries and Associations:
Here's who "These folks" are ...
"Sanofi to Invest at Least $20 Billion in US Through 2030"
